Recordati Rare Diseases Germany GmbH distributes prescription medicines for the treatment of rare diseases in Germany and is headquartered in Ulm, Eberhard-Finck-Strasse 55. Revenue for the 2024 fiscal year amounted to TEUR 55,603, split into Endocrinology TEUR 12,666, Metabolic TEUR 15,032 and Oncology TEUR 27,905. The company is a 100% subsidiary of Recordati Rare Diseases S.a.r.l., Puteaux (France) and purchases finished medicinal products from Recordati Rare Diseases S.a.r.l. and Recordati Netherlands B.V.; it does not conduct its own research and development. At year-end 46 employees were employed, including 29 Key Account Managers and 11 Medical Science Liaison Managers, and distribution is carried out mainly via direct sales to pharmacies and hospital pharmacies.
Der Vertrieb von Arzneimitteln und/oder Medikamenten jeglicher Art, insbesondere von Medikamenten zur Behandlung seltener Krankheiten im Gebiet der Bundesrepublik oder im Ausland.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 727718 (as of 21 August 2026)
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 727718 (as of 21 August 2026)
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 727718 (as of 21 August 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Ulm Local Court, HRB 727718 (as of 21 August 2026)
Sign in to view detailed salary and cost trends.
